Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.
A Mesa medical manufacturer of wound care products has achieved a milestone in its development of a treatment of leg ulcers that are difficult to heal. BioLab Holdings has started clinical trials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results